19-Mar-2026
SGRY Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates
Globe Newswire (Thu, 19-Mar 9:01 AM ET)
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES
PRNewswire (Wed, 18-Mar 9:45 AM ET)
Wave of Insider Selling Sweeps Through Surgery Partners’ Executive Ranks
TipRanks (Mon, 16-Mar 10:04 PM ET)
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
Globe Newswire (Thu, 12-Mar 6:12 PM ET)
Globe Newswire (Thu, 12-Mar 9:00 AM ET)
PRNewswire (Wed, 11-Mar 9:00 AM ET)
Ortelius Delivers Open Letter to Surgery Partners Stockholders
Business Wire (Tue, 10-Mar 11:00 AM ET)
Surgery Partners, Inc. to Present at Upcoming Investor Conference
Globe Newswire (Mon, 9-Mar 12:04 PM ET)
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
PRNewswire (Wed, 4-Mar 4:00 PM ET)
Globe Newswire (Wed, 4-Mar 8:31 AM ET)
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Surgery Partners trades on the NASDAQ stock market under the symbol SGRY.
As of March 19, 2026, SGRY stock price declined to $12.05 with 1,756,662 million shares trading.
SGRY has a beta of 1.38, meaning it tends to be more sensitive to market movements. SGRY has a correlation of 0.17 to the broad based SPY ETF.
SGRY has a market cap of $1.56 billion. This is considered a Small Cap stock.
Last quarter Surgery Partners reported $885 million in Revenue and $.12 earnings per share. This beat revenue expectation by $16 million and missed earnings estimates by -$.17.
In the last 3 years, SGRY traded as high as $45.79 and as low as $11.61.
The top ETF exchange traded funds that SGRY belongs to (by Net Assets): VTI, VB, IWM, VBR, VXF.
SGRY has underperformed the market in the last year with a price return of -50.5% while the SPY ETF gained +17.6%. SGRY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.2% and -14.6%, respectively, while the SPY returned -3.1% and -3.2%, respectively.
SGRY support price is $11.99 and resistance is $12.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGRY shares will trade within this expected range on the day.